Table 1.
Patients and treatments characteristics
| Characteristics | n (%); median [range] | |
|---|---|---|
| Number of patients | 114 (100) | |
| WHO status (%) | 0 | 85 (74.6) |
| 1 | 26 (22.8) | |
| 2 | 3 (2.6) | |
| Median age [range] | 46.91 [24.67–80.67] | |
| FIGO (%) | IB2-IIA | 36 (31.6) |
| IIB | 45 (39.5) | |
| IIIA-IIIB IVB |
18 (15.7) 15 (13.2) |
|
| Pelvic nodal metastases (%) | No | 64 (56.1) |
| Yes | 50 (43.9) | |
| Yes | 11 (9.6) | |
| Chronic diseases (%) | No | 103 (90.4) |
| Smoker (%) | No | 73 (64.0) |
| Yes | 41 (36.0) | |
| BMI, median [range] | 22.80 [16.00–44.10] | |
| Concurrent chemotherapy | 114 (100) | |
| Cisplatin (%) | 102 (89.5) | |
| Carboplatin (%) | 12 (10.5) | |
| Number of chemotherapy cycles (%) | ||
| 3 | 5 (4.4) | |
| 4 | 22 (19.3) | |
| 5 | 87 (76.3) | |
| Radiotherapy technique | ||
| 3DRT vs IMRT (%) | 3DRT | 86 (75.4) |
| IMRT | 28 (24.6) | |
| Para-aortic LN irradiation (%) | No | 99 (86.8) |
| Yes | 15 (13.2) |
Abbreviations: BMI, body mass index; FIGO, International Federation of Gynecology Obstetrics; 3DRT, 3D conformal radiotherapy; IMRT, intensity modulated radiotherapy; LN, lymph nodes; WHO, world Health Organization.